ultram overdose He rabbit. The dosages listed for mouse ultram overdose, rat and rabbit are 1.7 ultram overdose, 1.9 and 14.6 times the maximum daily human dosage (246 mg m2) ultram overdose, respectively. Non-teratogenic Effects Tramadol was evaluated in peri- and post-natal studies in rats. Progeny of dams receiving oral (gavage) dose levels of 50 mg kg (300 mg m2 or 1.2 times the maximum daily human tramadol dosage) or greater had decreased weights ultram overdose, and pup survival was decreased early in lactation at 80 mg kg (480 mg m2 or 1.9 and higher the maximum daily human dose). There are no adequate and well-controlled studies in pregnant women. ULTRAM should be used during pregnancy only if the potential benefit justifies the p ultram overdose.
ultram overdose Otential risk to the fetus. Neonatal seizures ultram overdose, neonatal withdrawal syndrome ultram overdose, fetal death and still birth have been reported during post-marketing. Labor and Delivery ULTRAM should not be used in pregnant women prior to or during labor unless the potential benefits outweigh the risks. Safe use in pregnancy has not been established. Chronic use during pregnancy may lead to physical dependence and post-partum withdrawal symptoms in the newborn (see DRUG ABUSE AND DEPENDENCE). Tramadol has been shown to cross the placenta. The mean ratio of serum tramadol in the umbilical veins compared to maternal veins was 0.83 for 40 women given tramadol during labor. The effect of ULTRAM ultram overdose, if any ultram overdose, on the later growth ultram overdose, development ultram overdose, and functional maturation of the child is unknown. Nursing Mothers ULTRAM is not recommended for obstetrical preoperative medication or for post-delivery analgesia in nursing mothers because its safety in infants and newborns has not been studied. Following a single IV 100 mg dose of tramadol ultram overdose, the cumulative excretion in breast milk within 16 hours postdose was 100 µg of tramadol (0.1% of the maternal dose) and 27 µg of M1. Pediatric Use The safety and efficacy of ULTRAM in patients under 16 years of age have not been established. The use of ULTRAM in the pediatric population is not recommended. Geriatr.
ultram overdose Ct of ULTRAM ultram overdose, if any ultram overdose, on the later growth ultram overdose, development ultram overdose, and functional maturation of the child is unknown. Nursing Mothers ULTRAM is not recommended for obstetrical preoperative medication or for post-delivery analgesia in nursing mothers because its safety in infants and newborns has not been studied. Following a single IV 100 mg dose of tramadol ultram overdose, the cumulative excretion in breast milk within 16 hours postdose was 100 µg of tramadol (0.1% of the maternal dose) and 27 µg of M1. Pediatric Use The safety and efficacy of ULTRAM in patients under 16 years of age have not been established. The use of ULTRAM in the pediatric population is not recommended. Geriatri.
ultram overdose
ultram overdose | | | | | | ultram overdose
|